Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients

Immunotherapy is currently investigated as treatment option in many types of cancer. So far, results from clinical trials have demonstrated that significant benefit from immunomodulatory therapies is restricted to patients with select histologies. To broaden the potential use of these therapies, a d...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncoimmunology
Päätekijät: Bücklein, Veit, Adunka, Tina, Mendler, Anna N., Issels, Rolf, Subklewe, Marion, Schmollinger, Jan C., Noessner, Elfriede
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006893/
https://ncbi.nlm.nih.gov/pubmed/27622032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1178421
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia